GentiBio, Inc
GentiBio, Inc. is a biotechnology company based in Cambridge, MA, specializing in the engineering of regulatory T cells (Tregs) to create optimized therapies for autoimmune, alloimmune, and inflammatory diseases. Their modular engineering platform allows for the development of tailored Tregs that enhance therapeutic efficacy while addressing key challenges in Treg manufacturing.
With a strong focus on fostering human potential within the life sciences career landscape, GentiBio aims to cultivate a collaborative and dedicated work environment. The company is committed to advancing patient care, as evidenced by recent FDA approvals and designations for their innovative Treg cell therapies.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.